主动脉壁内血肿患者的主动脉相关死亡与全因死亡
该研究对1999至2013年连续63例主动脉壁内血肿(IMH)患者进行事后分析,随访至2017年5月完成97%,平均随访6.3±3.6年。结果显示主动脉相关晚期死亡率低(9.5%),但全因晚期死亡率高达47.6%,且主动脉相关死亡仅发生在诊断后第一年内。
要点
- IMH患者晚期主动脉相关死亡率低,但全因死亡率较高。
- 主动脉相关死亡仅发生在诊断后第一年内。
- 第一年后很少需要干预,B型IMH干预后晚期死亡率无差异。
核心结论
- IMH晚期主动脉相关死亡率低,而全因死亡率较高。
- 主动脉相关死亡仅发生在诊断后第一年内,第一年后很少需要干预。
研究设计与样本
- 随访至2017年5月完成97%,平均随访6.3±3.6年,平均年龄71±9.2岁。
主要发现
- B型IMH免于干预率为40%,47%因入口撕裂、进展为急性B型夹层或主动脉扩张接受TEVAR,13%因降主动脉扩张接受开放手术。
- A型IMH中89%接受开放手术。
- 所有IMH患者主动脉相关30天、6个月、1年及晚期死亡率分别为1.6%、6.3%、6.3%、9.5%。
- 所有IMH患者全因30天、6个月、1年及晚期死亡率分别为1.6%、6.3%、6.3%、47.6%。
- B型IMH晚期死亡率在TEVAR、开放手术或仅最佳药物治疗组间无差异(26% vs. 22%,p=1.0)。
临床怎么用
- IMH患者诊断后第一年需密切监测主动脉相关死亡风险。
- 第一年后主动脉相关死亡风险低,干预需求少,可侧重管理全因死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prognosis of patients with intramural haematoma (IMH) of the aorta beyond the first year after diagnosis remains largely unknown. In particular, patients that do not undergo interventions are lost to follow-up. The aim was to assess medium-term outcome in IMH patients. METHODS: Post hoc analysis of 63 consecutive patients presenting with IMH between 1999 and 2013 was performed. Patients meeting imaging criteria at the first presentation were included even if follow-up imaging showed evidence of intimal disruption or false lumen flow. RESULTS: Eighteen patients presented with type A and 45 with type B IMH (29% vs. 71%, p < .001). The mean age was 71 ± 9.2 years, range 42-88 years. Follow-up was completed in 97% of patients by May 2017 and represents a mean follow-up of 6.3 ± 3.6 years. Freedom from intervention in patients with type B IMH was 40%. TEVAR was performed in 47% because of development, unmasking of an entry tear (57%), progression to acute type B dissection (24%), or subsequent dilation of the affected aortic segments (19%). Open repair was performed in 13% of type B IMH patients because of dilation of the descending aorta. In type A IMH, 89% underwent open repair. Aorta related 30 day, 6 month, 1 year, and late mortality were 1.6%, 6.3%, 6.3%, and 9.5%, respectively, for all IMH patients. All-cause 30 day, 6 month, 1 year, and late mortality were 1.6%, 6.3%, 6.3%, and 47.6%, respectively, for all IMH patients. Late mortality in type B IMH did not differ whether patients underwent TEVAR, open repair, or received best medical treatment only (26% vs. 22%, p = 1.0). CONCLUSIONS: Late aorta related mortality in IMH was low whereas all-cause mortality was substantial. Aorta related mortality in IMH patients only occurs during the first year after diagnosis. Interventions after the first year are rarely necessary.
引用
- Schoenhoff FS, Zanchin C, Czerny M, et al. Aorta Related and All-cause Mortality in Patients with Aortic Intramural Haematoma. Eur J Vasc Endovasc Surg. 2017. PMID: 28802635. doi:10.1016/j.ejvs.2017.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。